GST Authorities Demand Rs. 20.50 Crores From Dr. Agarwal's Health Care
Dr. Agarwal's Health Care Limited received a Show Cause Notice dated May 18, 2026, from the Office of the Assistant Commissioner, GST & Central Excise, Nungambakkam, Chennai. The notice alleges discrepancies such as differences in output turnover, short payment of tax under RCM, and excess ITC claims for the financial year 2023-24. The company faces a potential GST demand of Rs. 20.50 Crores, including interest and penalty, but stated it does not expect a material impact on its operations.
*this image is generated using AI for illustrative purposes only.
Dr. Agarwal's Health Care Limited has disclosed the receipt of a Show Cause Notice (SCN) from the Office of the Assistant Commissioner, GST & Central Excise, Nungambakkam, Chennai. The notice, dated May 18, 2026, alleges specific discrepancies regarding the returns and statements filed by the company for the financial year 2023-24.
Details of the Discrepancies
The authorities have cited several issues in the SCN, including a difference in output turnover and short payment of tax under the Reverse Charge Mechanism (RCM). Other allegations involve exempted, nil-rated, or non-GST supplies, an excess claim of Input Tax Credit (ITC), and the claim of ineligible ITC. The notice also points to non-compliance with e-invoicing norms and penalties for late or improper reporting.
Financial Implications
As per the SCN, the company is required to show cause within 30 days of receipt as to why a GST demand of Rs. 20.50 Crores, including interest and penalty, should not be levied. In response to the disclosure, the company management stated that it is currently examining the notice and intends to take appropriate steps, including the submission of a reply within the stipulated time frame.
| Particulars | Details |
|---|---|
| Authority | Office of the Assistant Commissioner, GST & Central Excise, Nungambakkam, Chennai |
| Date of Notice | May 18, 2026 |
| Period Under Review | Financial Year 2023-24 |
| Demand Amount | Rs. 20.50 Crores |
| Time to Respond | 30 days from receipt |
The company further clarified that it does not envisage any relevant impact on its financials, operations, or other activities as a result of this notice.
Historical Stock Returns for Dr. Agarwal's Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.36% | +7.42% | +4.79% | -2.92% | +22.42% | +19.35% |
If the GST authorities uphold the full demand of Rs. 20.50 Crores, how might this impact Dr. Agarwal's Health Care Limited's cash flow and upcoming expansion plans?
Could this SCN signal a broader regulatory scrutiny of GST compliance practices across the healthcare and diagnostics sector in India?
How might repeated GST notices or an adverse ruling affect Dr. Agarwal's Health Care Limited's valuation and investor sentiment ahead of any future fundraising or IPO activities?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
